Contrast echocardiography facilitates appropriate management of hospitalized patients with coronavirus disease 2019 (COVID-19) and suspected right ventricular masses: case series.
Christina BotrousGabriel BiohAshish PatelReinette HampsonRoxy SeniorPublished in: European heart journal. Case reports (2021)
Coronavirus disease 2019 infection is associated with peripheral thrombo-embolism and cardiac thrombi. Given the critical condition of many patients affected by COVID-19, imaging for thrombo-embolic events is often restricted. With the use of bedside CE, cardiac masses may be correctly identified, aiding proper adjustment of anticoagulation therapy.
Keyphrases
- coronavirus disease
- left ventricular
- end stage renal disease
- respiratory syndrome coronavirus
- contrast enhanced
- ejection fraction
- chronic kidney disease
- sars cov
- newly diagnosed
- magnetic resonance
- high resolution
- atrial fibrillation
- computed tomography
- venous thromboembolism
- pulmonary embolism
- pulmonary hypertension
- magnetic resonance imaging
- peritoneal dialysis
- heart failure
- stem cells
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- mass spectrometry
- fluorescence imaging